Stock Radar: Concord Biotech stock showing signs of rebound after falling over 20% from highs; time to buy
- Posted on August 4, 2026
- By Business News Today
- 0 Views
- 1 min read
In brief
Generating AI summary…
Stock Radar: Concord Biotech stock showing signs of rebound after falling over 20% from highs; time to buy
Concord Biotech stock shows a breakout from a seven-month consolidation phase. Experts suggest buying the stock for a target above 1,500 levels. The pharma stock experienced a significant fall after reaching record highs previously. It has since formed a strong base and is trading above key moving averages. Momentum indicators support a bullish outlook for the stock in the coming weeks.
